A. Bonito‐Oliva

发表

L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission

G. Fisone, M. Feyder, A. Bonito-Oliva, 2011, Front. Behav. Neurosci..

Convulsant Doses of a Dopamine D1 Receptor Agonist Result in Erk-Dependent Increases in Zif268 and Arc/Arg3.1 Expression in Mouse Dentate Gyrus

G. Fisone, J. Waddington, E. Valjent, 2011, PloS one.

Human Islet Amyloid Polypeptide (hIAPP) Protofibril‐Specific Antibodies for Detection and Treatment of Type 2 Diabetes

T. Sakmar, W. V. Graham, M. Kazmi, 2022, Advanced science.

Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates l-DOPA-induced dyskinesia in dopamine-denervated mice

N. Mercuri, G. Fisone, N. Berretta, 2014, Experimental Neurology.

Discovery of conformation-sensitive anti-amyloid protofibril monoclonal antibodies using an engineered chaperone-like amyloid-binding protein

C. Graff, T. Sakmar, J. Deguzman, 2019, bioRxiv.

Conformation‐specific antibodies against multiple amyloid protofibril species from a single amyloid immunogen

B. Winblad, L. Tjernberg, C. Graff, 2019, Journal of cellular and molecular medicine.

Role of Aberrant Striatal Dopamine D1 Receptor/cAMP/Protein Kinase A/DARPP32 Signaling in the Paradoxical Calming Effect of Amphetamine

D. Centonze, A. Pisani, N. Mercuri, 2010, The Journal of Neuroscience.

A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions

G. Fisone, D. Masini, A. Bonito-Oliva, 2014, Front. Behav. Neurosci..

Habituation to the test cage influences amphetamine-induced locomotion and Fos expression and increases FosB/ΔFosB-like immunoreactivity in mice

S. Cabib, C. Orsini, A. Bonito-Oliva, 2006, Neuroscience.

Cognitive Impairment and Dentate Gyrus Synaptic Dysfunction in Experimental Parkinsonism

N. Mercuri, G. Fisone, J. Kehr, 2014, Biological Psychiatry.

Higher free d-aspartate and N-methyl-d-aspartate levels prevent striatal depotentiation and anticipate l-DOPA-induced dyskinesia

P. Calabresi, B. Picconi, G. Fisone, 2011, Experimental Neurology.

A Genetic Locus Mediating Attentional Processing

J. Fak, P. Sethupathy, M. Kanke, 2023 .

Inhibition of mTORC1 Signaling Reverts Cognitive and Affective Deficits in a Mouse Model of Parkinson’s Disease

G. Fisone, D. Masini, A. Bonito-Oliva, 2018, Front. Neurol..

Dopamine Depletion Impairs Bilateral Sensory Processing in the Striatum in a Pathway-Dependent Manner

G. Silberberg, G. Fisone, Yvonne Johansson, 2017, Neuron.

Atypical but not typical antipsychotic drugs ameliorate phencyclidine-induced emotional memory impairments in mice

G. Fisone, O. Stiedl, Å. Konradsson-Geuken, 2019, European Neuropsychopharmacology.

Deciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 Signaling

G. Fisone, M. Feyder, A. Bonito-Oliva, 2011, Front. Neuroanat..

Understanding cognitive deficits in Parkinson's disease: lessons from preclinical animal models.

G. Fisone, R. Brambilla, A. Bonito-Oliva, 2013, Learning & memory.

Haloperidol Regulates the State of Phosphorylation of Ribosomal Protein S6 via Activation of PKA and Phosphorylation of DARPP-32

G. Fisone, J. Girault, E. Valjent, 2011, Neuropsychopharmacology.

Involvement of the Striatal Medium Spiny Neurons of the Direct Pathway in the Motor Stimulant Effects of Phencyclidine

G. Fisone, A. Bonito-Oliva, S. Ögren, 2015, The international journal of neuropsychopharmacology.

Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions

N. Mercuri, G. Fisone, N. Berretta, 2014, Neuropharmacology.

Energetics Underlying Twist Polymorphisms in Amyloid Fibrils.

S. Marrink, T. Huber, T. Sakmar, 2018, The journal of physical chemistry. B.

Anteromedial Thalamus Gates the Selection & Stabilization of Long-Term Memories

A. Bonito-Oliva, A. Toader, Suraj Kumar, 2023, Cell.

Genetic liability increases propensity to prime-induced reinstatement of conditioned place preference in mice exposed to low cocaine

S. Cabib, C. Orsini, A. Bonito-Oliva, 2008, Psychopharmacology.

The histamine H3 receptor antagonist thioperamide rescues circadian rhythm and memory function in experimental parkinsonism

G. Fisone, A. Fisahn, D. Masini, 2017, Translational Psychiatry.

Susceptibility to conditioned place preference induced by addictive drugs in mice of the C57BL/6 and DBA/2 inbred strains

S. Cabib, C. Orsini, A. Bonito-Oliva, 2005, Psychopharmacology.

Activation of metabotropic glutamate 4 receptors decreases L-DOPA-induced dyskinesia in a mouse model of Parkinson's disease.

G. Fisone, F. Acher, S. Lopez, 2011, Journal of Parkinson's disease.

DeltaFosB accumulation in ventro‐medial caudate underlies the induction but not the expression of behavioral sensitization by both repeated amphetamine and stress

S. Cabib, C. Orsini, D. Conversi, 2007, The European journal of neuroscience.

Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates l-DOPA-induced dyskinesia in dopamine-denervated mice

N. Mercuri, G. Fisone, N. Berretta, 2014, Experimental Neurology.

On the Role of Adenosine A2A Receptor Gene Transcriptional Regulation in Parkinson’s Disease

G. Fisone, E. Dainese, F. Fattapposta, 2019, Front. Neurosci..

Haloperidol Regulates the State of Phosphorylation of Ribosomal Protein S6 via Activation of PKA and Phosphorylation of DARPP-32

G. Fisone, J. Girault, E. Valjent, 2011, Neuropsychopharmacology.

Haloperidol promotes mTORC1-dependent phosphorylation of ribosomal protein S6 via dopamine- and cAMP-regulated phosphoprotein of 32 kDa and inhibition of protein phosphatase-1

G. Fisone, J. Girault, E. Valjent, 2013, Neuropharmacology.

Differential regulation of the phosphorylation of Trimethyl-lysine27 histone H3 at serine 28 in distinct populations of striatal projection neurons

G. Fisone, Xiaochen Hu, A. Bonito-Oliva, 2016, Neuropharmacology.